Details of Disease | DrugMAP

General Information of Disease (ID: DISO81VK)

Disease Name	Metastatic breast cancer
Disease Class	2C60-2C6Y: Breast cancer
Disease Hierarchy	DIS01GPL: Grass pollen hypersensitivity DISO81VK: Metastatic breast cancer
ICD Code	ICD-11 ICD-11: 2C6Y

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Balixafortide	DMUOFAC	Phase 3	Peptide	[1]
Encequidar	DMM8Z3Q	Phase 2	Small molecular drug	[2]
ORIN1001	DM27RXS	Phase 1/2	Small interfering RNA	[3]
PMD-026	DMIS8BV	Phase 1	Small molecular drug	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT03786094) Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer (FORTRESS). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01042379) I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY). U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT03950570) ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer. U.S. National Institutes of Health.
4	ClinicalTrials.gov (NCT04115306) Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer. U.S. National Institutes of Health.